This is not a paywall.

Register for free to continue reading.

The news sucks. But your reading experience doesn't have to. Help us improve that for you by registering for free.

Please create a password or click to receive a login link.

Please enter your password or get a login link if you’ve forgotten

Open Sesame! Thanks for registering.

First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

Peltz’s Activist Fund Trian Is Said to Build Stake in...

Business Maverick

Business Maverick

Peltz’s Activist Fund Trian Is Said to Build Stake in Unilever

Nelson Peltz in 2016. Photographer: Patrick T. Fallon/Bloomberg
By Bloomberg
24 Jan 2022 0

Nelson Peltz’s activist hedge fund Trian Fund Management has built a stake in Unilever Plc, according to people familiar with the matter, adding pressure on Chief Executive Officer Alan Jope after a failed bid to buy GlaxoSmithKline Plc’s consumer-health unit.

The U.S. fund has bought a meaningful stake in the Dove soap owner over the past few months, said the people, asking not to be identified because the plans are private. The exact size of the stake or Peltz’s intentions couldn’t be immediately learned.

Billionaire Peltz is turning his attention to Unilever after retiring from Procter & Gamble Co.’s board in August after nearly four years and several dramatic changes aimed at improving performance at the consumer-goods giant.

Unilever shares recorded their worst weekly loss since the peak of the pandemic selloff in March 2020 after it confirmed on Jan. 16 that it offered 50 billion pounds ($68 billion) for the healthcare unit, which includes brands such as Advil and Sensodyne. GSK rejected the bid as too low, and Unilever later said it had no plans to raise the offer.

CEO Jope’s public defeat came after analysts implored him not to pursue the Glaxo unit. Fund manager Terry Smith called the GSK bid a “near-death experience.” Only days earlier, he had urged Unilever to focus more on fixing its own business rather than seeking to promote the sustainability ethos of brands such as Hellmann’s mayonnaise.

Read More: Unilever CEO Misses Out on Advil Just as He May Need It (2)

The Financial Times earlier reported the Trian stake. Representatives for the hedge fund and Unilever declined to comment.

It remains to be seen whether Jope’s setback with GSK will prompt the kind of radical changes implemented at Unilever after Kraft Heinz Co.’s failed bid to acquire Unilever in 2017 for $143 billion. That debacle led Unilever to consolidate its headquarters in the U.K., ditch a cumbersome Anglo-Dutch structure, and adopt a more aggressive acquisition strategy.

Unilever shares could benefit from Peltz’s stake-building on Monday. Trian, which was co-founded by Peltz, Ed Garden and Peter May, has a history of pushing for changes at consumer companies, including PepsiCo Inc., Danone SA, Kraft Foods Inc. and others.

“Trian has a long and successful track record of unlocking value,” wrote Jefferies analysts led by Martin Deboo. He expects Trian to argue for splitting Unilever’s food business from hits household and personal care operations.


Comments - share your knowledge and experience

Please note you must be a Maverick Insider to comment. Sign up here or sign in if you are already an Insider.

Everybody has an opinion but not everyone has the knowledge and the experience to contribute meaningfully to a discussion. That’s what we want from our members. Help us learn with your expertise and insights on articles that we publish. We encourage different, respectful viewpoints to further our understanding of the world. View our comments policy here.

No Comments, yet

Please peer review 3 community comments before your comment can be posted